Sherrie and Alan Conover Center for Liver Disease & Transplantation

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Transplants 75%
3. Non-alcoholic Fatty Liver Disease 59%
4. Allografts 49%
5. Transplant Recipients 46%
6. Kidney 40%
7. Kidney Transplantation 35%
8. T-Lymphocytes 32%
9. Tissue Donors 30%
10. Liver 30%
11. Pancreas Transplantation 30%
12. Transplantation 29%
13. Fibrosis 29%
14. Hepatocellular Carcinoma 26%
15. Pancreas 25%
16. Liver Diseases 23%
17. Fatty Liver 22%
18. Neoplasms 18%
19. Living Donors 17%
20. Therapeutics 17%
21. Transplantation Tolerance 17%
22. Survival 16%
23. Graft Survival 16%
24. Graft Rejection 16%
25. Macrophages 16%
26. Immunosuppression 16%
27. Organ Transplantation 15%
28. Tacrolimus 12%
29. Genome 12%
30. Mortality 11%
31. Hepatitis C 11%
32. Cholangiocarcinoma 11%
33. Immunosuppressive Agents 11%
34. Meta-Analysis 10%
35. End Stage Liver Disease 10%
36. Natural Killer Cells 10%
37. Elasticity Imaging Techniques 10%
38. Biopsy 9%
39. Sirolimus 9%
40. Heart 9%
41. Cyclosporine 9%
42. Drainage 9%
43. Antibodies 8%
44. Regulatory T-Lymphocytes 8%
45. Placebos 8%
46. Serum 8%
47. Hepacivirus 8%
48. Pancreatic Neoplasms 7%
49. Psychology Rejection 7%
50. Incidence 7%
51. Pancreatitis 7%
52. Liver Neoplasms 7%
53. Recurrence 7%
54. Interleukin-15 7%
55. Interleukin-2 7%
56. Systematic Reviews 7%
57. Multicenter Studies 7%
58. Mycophenolic Acid 7%
59. Liver Cirrhosis 7%
60. Infections 6%
61. Insulin 6%
62. Islets of Langerhans Transplantation 6%
63. Cytokines 6%
64. Obesity 6%
65. Pediatrics 6%
66. Quality of Life 6%
67. Phenotype 6%
68. Innate Immunity 6%
69. Safety 6%
70. Genes 5%
71. Coronavirus 5%
72. Clinical Trials 5%
73. Immunity 5%
74. thymoglobulin 5%
75. Muromonab-CD3 5%
76. Wounds and Injuries 5%
77. Lung 5%
78. SARS Virus 5%
79. Islets of Langerhans 5%
80. Population 5%
81. firsocostat 5%
82. Alcohols 5%
83. African Americans 5%
84. Fats 5%
85. Heart Transplantation 5%
86. Mutation 5%
87. Survival Rate 5%
88. Antiviral Agents 5%
89. Creatinine 5%
90. Type 1 Diabetes Mellitus 5%